BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28811278)

  • 1. Lipodystrophic laminopathy: Lamin A mutation relaxes chromatin architecture to impair adipogenesis.
    Elzeneini E; Wickström SA
    J Cell Biol; 2017 Sep; 216(9):2607-2610. PubMed ID: 28811278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A lipodystrophy-causing lamin A mutant alters conformation and epigenetic regulation of the anti-adipogenic
    Oldenburg A; Briand N; Sørensen AL; Cahyani I; Shah A; Moskaug JØ; Collas P
    J Cell Biol; 2017 Sep; 216(9):2731-2743. PubMed ID: 28751304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks.
    Briand N; Guénantin AC; Jeziorowska D; Shah A; Mantecon M; Capel E; Garcia M; Oldenburg A; Paulsen J; Hulot JS; Vigouroux C; Collas P
    Hum Mol Genet; 2018 Apr; 27(8):1447-1459. PubMed ID: 29438482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulation of Fragile X-related protein 1 by the lipodystrophic lamin A p.R482W mutation elicits a myogenic gene expression program in preadipocytes.
    Oldenburg AR; Delbarre E; Thiede B; Vigouroux C; Collas P
    Hum Mol Genet; 2014 Mar; 23(5):1151-62. PubMed ID: 24108105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Itm2a silencing rescues lamin A mediated inhibition of 3T3-L1 adipocyte differentiation.
    Davies SJ; Ryan J; O'Connor PBF; Kenny E; Morris D; Baranov PV; O'Connor R; McCarthy TV
    Adipocyte; 2017 Oct; 6(4):259-276. PubMed ID: 28872940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Familial partial lipodystrophy (Dunnigan syndrome) due to LMNA gene mutation: The first description of its clinical case in Russia].
    Sorkina EL; Kalashnikova MF; Melnichenko GA; Tyulpakov AN
    Ter Arkh; 2015; 87(3):83-87. PubMed ID: 26027246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p.R482W substitution in A-type lamins deregulates SREBP1 activity in Dunnigan-type familial partial lipodystrophy.
    Vadrot N; Duband-Goulet I; Cabet E; Attanda W; Barateau A; Vicart P; Gerbal F; Briand N; Vigouroux C; Oldenburg AR; Lund EG; Collas P; Buendia B
    Hum Mol Genet; 2015 Apr; 24(7):2096-109. PubMed ID: 25524705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico investigation of molecular mechanism of laminopathy caused by a point mutation (R482W) in lamin A/C protein.
    Rajendran V; Purohit R; Sethumadhavan R
    Amino Acids; 2012 Aug; 43(2):603-15. PubMed ID: 21989830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial partial lipodystrophy due to the LMNA R482W mutation with multinodular goitre, extrapyramidal syndrome and primary hyperaldosteronism.
    Vantyghem MC; Faivre-Defrance F; Marcelli-Tourvieille S; Fermon C; Evrard A; Bourdelle-Hego MF; Vigouroux C; Defebvre L; Delemer B; Wemeau JL
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):247-9. PubMed ID: 17524034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of phenotypes in male and female individuals of a new family with Dunnigan type of familial partial lipodystrophy due to a lamin A/C R482W mutation.
    Laudes M; Oberhauser F; Walgenbach K; Schubert M; Schulte DM; Faust M; Krone W
    Horm Metab Res; 2009 May; 41(5):414-7. PubMed ID: 19204888
    [No Abstract]   [Full Text] [Related]  

  • 11. FPLD2 LMNA mutation R482W dysregulates iPSC-derived adipocyte function and lipid metabolism.
    Friesen M; Cowan CA
    Biochem Biophys Res Commun; 2018 Jan; 495(1):254-260. PubMed ID: 29108996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamin A/C mutation associated with lipodystrophy influences adipogenic differentiation of stem cells through interaction with Notch signaling.
    Perepelina K; Dmitrieva R; Ignatieva E; Borodkina A; Kostareva A; Malashicheva A
    Biochem Cell Biol; 2018 Jun; 96(3):342-348. PubMed ID: 29040816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological and molecular features of lipomatous and nonlipomatous adipose tissue in familial partial lipodystrophy caused by LMNA mutations.
    Araújo-Vilar D; Victoria B; González-Méndez B; Barreiro F; Fernández-Rodríguez B; Cereijo R; Gallego-Escuredo JM; Villarroya F; Pañeda-Menéndez A
    Clin Endocrinol (Oxf); 2012 Jun; 76(6):816-24. PubMed ID: 21883346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dunnigan-type familial partial lipodystrophy associated with the heterozygous R482W mutation in LMNA gene - case study of three women from one family.
    Nabrdalik K; Strózik A; Minkina-Pędras M; Jarosz-Chobot P; Młynarski W; Grzeszczak W; Gumprecht J
    Endokrynol Pol; 2013; 64(4):306-11. PubMed ID: 24002959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LMNA missense mutations causing familial partial lipodystrophy do not lead to an accumulation of prelamin A.
    Tu Y; Sánchez-Iglesias S; Araújo-Vilar D; Fong LG; Young SG
    Nucleus; 2016 Sep; 7(5):512-521. PubMed ID: 27841971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of familial partial lipodystrophy caused by a novel lamin A/C (LMNA) mutation in exon 1 (D47N).
    Kutbay NO; Yurekli BS; Onay H; Altay CT; Atik T; Hekimsoy Z; Saygili F; Akinci B
    Eur J Intern Med; 2016 Apr; 29():37-9. PubMed ID: 26775134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial partial lipodystrophy linked to a novel peroxisome proliferator activator receptor -γ (PPARG) mutation, H449L: a comparison of people with this mutation and those with classic codon 482 Lamin A/C (LMNA) mutations.
    Demir T; Onay H; Savage DB; Temeloglu E; Uzum AK; Kadioglu P; Altay C; Ozen S; Demir L; Cavdar U; Akinci B
    Diabet Med; 2016 Oct; 33(10):1445-50. PubMed ID: 26756202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of LMNA in adipose: a novel mouse model of lipodystrophy based on the Dunnigan-type familial partial lipodystrophy mutation.
    Wojtanik KM; Edgemon K; Viswanadha S; Lindsey B; Haluzik M; Chen W; Poy G; Reitman M; Londos C
    J Lipid Res; 2009 Jun; 50(6):1068-79. PubMed ID: 19201734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipodystrophy-linked LMNA p.R482W mutation induces clinical early atherosclerosis and in vitro endothelial dysfunction.
    Bidault G; Garcia M; Vantyghem MC; Ducluzeau PH; Morichon R; Thiyagarajah K; Moritz S; Capeau J; Vigouroux C; Béréziat V
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2162-71. PubMed ID: 23846499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The R439C mutation in LMNA causes lamin oligomerization and susceptibility to oxidative stress.
    Verstraeten VL; Caputo S; van Steensel MA; Duband-Goulet I; Zinn-Justin S; Kamps M; Kuijpers HJ; Ostlund C; Worman HJ; Briedé JJ; Le Dour C; Marcelis CL; van Geel M; Steijlen PM; van den Wijngaard A; Ramaekers FC; Broers JL
    J Cell Mol Med; 2009 May; 13(5):959-71. PubMed ID: 19220582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.